APA (7th ed.) Citation

Bicak, M., Perez‐Garcia, G. E., Buros, J., Haure‐Mirande, J., Perez, G. E., Otero‐Pagan, A., . . . Gandy, S. (2022). BCI‐838, an orally active mGluR2/3 antagonist pro‐drug, mimics the beneficial effects of physical exercise on neurogenesis, behavior and exercise‐related molecular pathways in an Alzheimer's disease mouse model. Alzheimer's & dementia: the journal of the Alzheimer's Association, 18(10), 1. https://doi.org/10.1002/alz.062751

Chicago Style (17th ed.) Citation

Bicak, Mesude, et al. "BCI‐838, an Orally Active MGluR2/3 Antagonist Pro‐drug, Mimics the Beneficial Effects of Physical Exercise on Neurogenesis, Behavior and Exercise‐related Molecular Pathways in an Alzheimer's Disease Mouse Model." Alzheimer's & Dementia: The Journal of the Alzheimer's Association 18, no. 10 (2022): 1. https://doi.org/10.1002/alz.062751.

MLA (9th ed.) Citation

Bicak, Mesude, et al. "BCI‐838, an Orally Active MGluR2/3 Antagonist Pro‐drug, Mimics the Beneficial Effects of Physical Exercise on Neurogenesis, Behavior and Exercise‐related Molecular Pathways in an Alzheimer's Disease Mouse Model." Alzheimer's & Dementia: The Journal of the Alzheimer's Association, vol. 18, no. 10, 2022, p. 1, https://doi.org/10.1002/alz.062751.